DNA methylation: an epigenetic risk factor in preterm birth

Ramkumar Menon1, Karen N Conneely, Alicia K Smith

  • 1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, The University of Texas Medical Branch at Galveston, TX 77555, USA. ram.menon@utmb.edu

Insights

Epigenetic changes, like DNA methylation, may increase the risk of spontaneous preterm birth (PTB). Understanding these epigenetic patterns is crucial for identifying risks and long-term health consequences in newborns.

Area of Science:

  • Reproductive Epigenetics
  • Perinatal Health
  • Developmental Origins of Health and Disease (DOHaD)

Background:

  • Spontaneous preterm birth (PTB) is a complex condition with poorly understood causes.
  • Pregnancy-related factors may induce epigenetic modifications, such as DNA methylation, influencing PTB risk.
  • Epigenetic changes can have lasting effects on neonatal health and predispose to adult-onset diseases.

Purpose of the Study:

  • To review the potential role of DNA methylation as a risk factor for spontaneous preterm birth (PTB).
  • To discuss the implications of epigenetic changes in PTB for long-term health outcomes.
  • To highlight considerations and limitations for future DNA methylation studies in PTB.

Main Methods:

  • Literature review of studies investigating DNA methylation and PTB.
  • Synthesis of current hypotheses on epigenetic mechanisms in PTB etiology.
  • Analysis of the impact of DNA methylation on gene expression timing during pregnancy.

Main Results:

  • Evidence suggests DNA methylation patterns are associated with spontaneous preterm birth risk.
  • Epigenetic modifications induced by pregnancy risk factors may play a significant role.
  • Identified epigenetic patterns could have long-term consequences for neonates.

Conclusions:

  • DNA methylation is a critical area of research for understanding spontaneous preterm birth.
  • Further investigation into epigenetic patterns is needed to identify at-risk pregnancies and improve neonatal outcomes.
  • Methodological considerations are essential for robust DNA methylation research in PTB.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...